A molecular diagnostic test for detecting ESR1 mutations in tumor diagnostics. Used for biomarker analysis in cancer precision medicine.
Manufactured by
Dresden, Germany
BIOTYPE is a German in vitro diagnostics and medical device company, headquartered in Dresden, capital city of Saxony. With over 20 years of experience, we develop, manufacture, and distribute products systems for molecular precision diagnostics and analysis of DNA RNA biomarkers. BIOTYPE also provides high-quality and IVD-compliant contract development manufacturing services. Founded in 1999, the company has extensive expertise in providing high-quality technologies, products, and services for molecular diagnostics to professional laboratories, biotech companies, Big Pharma, and MedTech/diagnostics companies worldwide. BIOTYPE offers a strong portfolio in molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, and molecular profiling of solid tumors. The portfolio includes IVD assays for clinical diagnostics, RUO assays for translational and clinical research, and a benchtop system for automated molecular profiling. The molecular test systems are used by professional laboratories to support accurate diagnoses of cancer patients, selecting the best possible treatment option, and aiding in the timely identification of actionable biomarkers for molecular-guided therapy. BIOTYPE provides its full value chain in molecular test development as services for contract development and contract manufacturing to academic and commercial partners worldwide. All of BIOTYPE's products and services are provided with highest quality standards.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GeneCker Co., Ltd.
South Korea · 1 relevant product
HLB PANAGENE Co., Ltd.
South Korea · 4 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 5 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
Shanghai Devulon Material Co.,Ltd
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
GMA Group Trading
Egypt · 1 relevant product
INFUNG Co., Ltd.
Taiwan · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 94 closest product alternatives
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
HLB PANAGENE Co., Ltd. · South Korea
A diagnostic assay for detection of KRAS mutations in colorectal and other cancers using PNA-based technology for precision medicine applications.
HLB PANAGENE Co., Ltd. · South Korea
An enhanced KRAS mutation detection test providing improved sensitivity and expanded mutation panel coverage for oncology diagnostics.
HLB PANAGENE Co., Ltd. · South Korea
A molecular diagnostic test for detection of ROS1 gene fusions in lung cancer patients using advanced nucleic acid technology.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for inherited genetic disorder detection. Identifies mutations and genetic variations associated with hereditary diseases.
HLB PANAGENE Co., Ltd. · South Korea
A diagnostic test for NRAS mutation detection in melanoma and other cancers, supporting personalized cancer treatment selection.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based diagnostic solution for early detection of esophageal cancer. Enables risk assessment and molecular diagnosis of esophageal malignancies.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.
Shanghai Devulon Material Co.,Ltd · China
A companion diagnostic test kit designed for detecting KRAS mutations in cancer samples. This kit is used in conjunction with specific therapeutic treatments for patients with companion diagnostic indications. The kit includes quality control materials and has been validated for clinical use in tumor sample analysis.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test for guiding cancer treatment selection and predicting therapeutic drug response. Utilizes DNA methylation analysis to optimize personalized cancer treatment strategies.
GMA Group Trading · Egypt
Molecular test for detection of epidermal growth factor receptor mutations in lung cancer diagnosis.
82 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products